OpenAI has quietly reversed a major change to how hundreds of millions of people use ChatGPT. On a low-profile blog that tracks product changes, the company said that it rolled back ChatGPT’s model ...

The Trump administration has unveiled a new payment model that could extend Medicare coverage to functional or lifestyle medicine providers. Under the Make America Healthy Again: Enhancing Lifestyle ...

The race to release world models is on as AI image and video generation company Runway joins an increasing number of startups and Big Tech companies by launching its first one. Dubbed GWM-1, the model ...

Which electric sedan should you buy in 2026? We compare Tesla’s high-performance Model 3 with BMW’s updated i4 to find the better value. The Tesla Model 3 Performance offers superior acceleration, ...

If you weren't already dreaming of being his next Sally, you are now Rachel DeSantis is a senior writer on the music team at PEOPLE. She has been working at PEOPLE since 2019, and her work has ...

The new Tesla Model Y Standard and Model 3 Standard are $5,000 and $5,500 more affordable than the rest of the lineup, respectively. Tesla cut a laundry list of features from the cars to make them ...

Tesla has finally introduced the long-awaited, cheaper versions of its Model Y and Model 3 cars. The new cars, which the company unveiled in an X post on Tuesday, Oct. 7, are the brand’s most ...

Tesla on Tuesday unveiled plans to sell cheaper alternatives of its Model Y and Model 3 cars, its first product release in years, as Elon Musk’s automaker created more affordable options for its ...

For nearly two decades, CEO Elon Musk has promised Tesla would make a more affordable electric vehicle, to, as he put it in 2006, “help expedite the move from a mine-and-burn hydrocarbon economy ...

After months of teasing, Tesla has finally revealed its cheapest Model Y yet that comes with less to offer—the most important of which is less price. As it turns out, Tesla was doing similar things to ...

For the field of drug development, hitting the right target with atomic precision to achieve therapeutic effect remains the core challenge. While traditional R&D pipelines are dependent on ...